News & Press Releases

2010

August 31, 2010
GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program

August 26, 2010
Xcellerex Signs Memorandum of Understanding with SK Chemicals to Commercialize SK-Developed Vaccines with FlexFactory® Platform.

June 9, 2010
Xcellerex announces groundbreaking for new FlexFactory facility.

May 17, 2010
Xcellerex and partners announce completion of successful test of Rapid Production of Swine Flu H1 Hemagglutinin.

April 12, 2010
Xcellerex Announces Appointment of Guy Broadbent as President and Chief Executive Officer.

March 4, 2010
Humacyte and Xcellerex Announce Collaboration to Develop Single-use Manufacturing Technology for Growth of Vascular Grafts for Transplantation.

January 12, 2010
Xcellerex Initiates Phase I Clinical Trial of Novel Yellow Fever Vaccine.

---

2009

October 21, 2009
Novavax and Xcellerex announce collaboration to develop large-scale manufacturing process for 2009 H1N1 Influenza VLP Vaccine.

October 1, 2009
Itero Biopharmaceuticals selects Xcellerex to enable cost effective production of specialty biopharmaceutical protein products.

June 17, 2009
Xcellerex announces milestone sale of FlexFactory® biomanufacturing line and XDR single-use bioreactors to Crucell, N.V.

April 28, 2009
Xcellerex Founder/CTO Parrish Galliher to be featured on upcoming industry panels.

April 1, 2009
David J. Williams, Retired Chairman/CEO of Sanofi Pasteur, joins Xcellerex Board of Directors

March 24, 2009
Xcellerex is awarded $11 Million Phase 2 U.S. Contract to Develop Technology for Accelerated Monoclonal Antibody and Vaccine Manufacturing

---

2008

September 25, 2008
Xcellerex and Novavax recognized at the 2008 Clinton Global Initiative Annual Meeting
Click here to listen to an exerpt

August 27, 2008
Forbes.com features Xcellerex as driving force in healthcare innovation

July 1, 2008
Cellon, S.A. to represent Xcellerex in key European markets

May 6, 2008
Parrish Galliher to be featured speaker on three expert panels at BIO 2008

April 10, 2008
Parrish Galliher to Speak at 6th Annual Biodefense Vaccines & Therapeutics Conference

March 10, 2008
Xcellerex introduces 2000 Liter XDR GMP Single-Use Bioreactor.

March 6, 2008
Xcellerex technologists to be featured speakers at Interphex 2008.

March 4, 2008
Xcellerex founder Parrish Galliher to speak at ISPE event in Denmark.

---

2007

October 11, 2007
Xcellerex raises $31 million in Series C financing.

September 5, 2007
Xcellerex to Present Results Of First Known 1000 Liter Working Volume Perfusion Cell Culture Using Disposable Technology

July 17, 2007
Xcellerex receives Two Phase I DARPA contracts.

May 4, 2007
Xcellerex announces appointment of Joseph Zakrzewski as Chief Executive Officer.

April 9, 2007
Xcellerex announces appointment of John Chickosky as Chief Operating Officer.